Chandra P Belani
Hershey Medical Center · City of Hope Medical Center · Milton S. Hershey Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chandra P Belani as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:52 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02403895 · AZD2014 and Weekly Paclitaxel in Squamous NSCLCAstraZeneca · terminated · Squamous Non Small Cell Lung Cancer · principal investigator
- Ph2NCT01413750 · Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung CancerNational Cancer Institute (NCI) · terminated · Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7 · principal investigator
- N/ANCT01398124 · Cyclin B1 Peptide-Pulsed Autologous Dendritic Cell Vaccine for Resectable Non-Small Cell Lung CancerMilton S. Hershey Medical Center · withdrawn · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT00766246 · Phase II Avastin Trial for Stage IIIB/IV NSCLCPharmatech · terminated · Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV · principal investigator
- Ph1NCT00714246 · Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerMilton S. Hershey Medical Center · terminated · Non Small Cell Lung Cancer · principal investigator
- Ph1NCT00702572 · Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerMilton S. Hershey Medical Center · terminated · Non-small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT00702962 · Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung CancerMilton S. Hershey Medical Center · terminated · Small Cell Lung Cancer · principal investigator
- Ph2NCT00469976 · Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerEastern Cooperative Oncology Group · withdrawn · Lung Cancer · unknown
- Ph3NCT00113386 · Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung CancerRadiation Therapy Oncology Group · terminated · Lung Cancer · study chair
- Ph1NCT00003147 · Gene Therapy in Treating Patients With Cancer of The LiverNational Cancer Institute (NCI) · terminated · Liver Cancer · study chair
- Ph1NCT00008125 · Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid TumorsUniversity of Pittsburgh · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph1NCT00009828 · Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid TumorsUniversity of Pittsburgh · withdrawn · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph1NCT00009815 · Combination Chemotherapy in Treating Patients With Advanced Solid TumorsUniversity of Pittsburgh · withdrawn · Unspecified Adult Solid Tumor, Protocol Specific · study chair
- Ph3NCT00003235 · Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically RemovedEastern Cooperative Oncology Group · completed · Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- CLINICAL TRIAL: PI & PHARMACOKINETIC STUDY OF DRUG FOR SOLID TUMORS & LYMPHOMASM01RR010732 · NCRR · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · fiscal years 2009 · $925 awarded in 2009Same name and institution; not confirmed by an ID
- Phase I Clinical Trials of Novel Anticancer AgentsU01CA099168 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2003 to 2006 · $428,535 awarded in 2006Grant number is on one of their registry trials
- PHASE I PHARMACOKINETIC STUDY OF CARBOPLATIN IN COMBO WITH WEEKLY PACLITAXELM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 1996 to 2000 · $3,034 awarded in 2000Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Leadership, Planning and EvaluationP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026Named on NCT01413750
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:52 UTC. The ranking covers the 200 most relevant of 113 PubMed records, and a shared surname and initials can bring in a namesake. All 113 on PubMed
- Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N Engl J Med · 20024,388 citationsRCR 91.8
- 2,159 citationsRCR 43.7
- 900 citationsRCR 20.7
- 761 citationsRCR 15.8
- 572 citationsRCR 25.9
- 354 citationsRCR 7.3
- 323 citationsRCR 7.4
- Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.J Clin Oncol · 2008287 citationsRCR 6.3
- 267 citationsRCR 5.7
- Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys · 2019247 citationsRCR 11.3